XML 37 R25.htm IDEA: XBRL DOCUMENT v3.7.0.1
EARNINGS PER SHARE (Tables)
6 Months Ended
Jun. 30, 2017
EARNINGS PER SHARE  
Schedule of basic and diluted loss per share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended June 30, 

 

Six Months Ended June 30, 

 

 

 

    

2017

    

2016

    

2017

    

 

2016

    

 

 

 

 

 

 

Net loss, basic

 

$

(27,520)

 

$

(17,475)

 

$

(54,997)

 

$

(51,263)

 

 

Effect of dilutive securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Change in fair value of warrants liability

 

 

 —

 

 

(159)

 

 

(24)

 

 

(4,740)

 

 

Net loss, diluted

 

$

(27,520)

 

$

(17,634)

 

$

(55,021)

 

$

(56,003)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares used in calculating basic net loss per common share

 

 

66,110

 

 

64,360

 

 

65,901

 

 

58,258

 

 

Effect of dilutive securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Effect of dilutive stock options, RSUs

 

 

 

 

 

 

 

 

 —

 

 

 —

 

 

Warrants to purchase common shares - liability-classified

 

 

 —

 

 

 3

 

 

 —

 

 

104

 

 

Shares used in calculating diluted net loss per common share

 

 

66,110

 

 

64,363

 

 

65,901

 

 

58,362

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss per common share, basic

 

$

(0.42)

 

$

(0.27)

 

$

(0.83)

 

$

(0.88)

 

 

Net loss per common share, diluted

 

$

(0.42)

 

$

(0.27)

 

$

(0.83)

 

$

(0.96)

 

 

 

Potential common shares excluded from the calculation of diluted net loss per share

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended June 30, 

 

Six Months Ended June 30, 

 

 

    

2017

    

2016

    

2017

    

2016

    

 

 

 

 

 

 

 

 

 

 

Options to purchase common shares, RSUs and PSUs

 

9,128

 

7,334

 

9,128

 

7,334

 

Warrants to purchase common shares - equity-classified

 

884

 

3,561

 

884

 

992

 

2022 Notes convertible into common shares

 

9,057

 

9,057

 

9,057

 

9,057

 

 

Summary of warrants outstanding and exercisable

 

 

 

 

 

 

 

 

No. of Warrants

 

Weighted-Average

Quarterly period of expiration

    

Outstanding

    

Exercise Price

 

 

 

 

 

 

Q1 2018

 

599

 

$

4.12

Q3 2018

 

16

 

$

3.78

Q4 2019

 

108

 

$

4.81

Q3 2020

 

110

 

$

4.09

Q1 2021

 

51

 

$

2.91

 

 

884

 

$

4.13